1-5 of 5
Eva Villamón, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myelodysplastic Syndromes with 20q Deletion: Incidence, Prognostic Value and Impact on Response to Azacitidine of ASXL1 Chromosomal Deletion and Genetic Mutations

Iván Martín, PhD, Eva Villamón, PhD, Rosario Abellán, PhD, Maria Jose Calasanz, PhD BSc, Aroa Irigoyen, PhD, Guillermo F Sanz, MD PhD, Esperanza Such, PhD, Elvira Mora Casterá, MD, Míriam Gutiérrez, PhD, Rosa Collado, MD, Míriam Vara, PhD, Laura Blanco, MD, Itziar Oiartzabal, MD, Sara Álvarez, PhD, Teresa Bernal del Castillo, MD PhD, Isabel Granada, PhD, Blanca Xicoy, MD, Lurdes Zamora, PhD, Andres Jerez, MDPhD, Raquel Fernández, PhD, Marisa Calabuig, MD, Francisca García, Alejandro Sanz, MD, Rosana Díez, MD, Ángela Gil, MD, Raquel de Paz, MD, Francisca López, MD, Teresa González, MD, Carlos Solano, MD PhD, Mar Tormo, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-139588
Published: 2020
Journal Articles

Impact of Clinical Features, Cytogenetics, Genetic Mutations and Methylation of CDKN2B and DLC-1 Promoters on Treatment Response to Azacitidine

Iván Martín, Alicia Serrano, Blanca Navarro, MD PhD, Eva Villamón, PhD, Marisa Calabuig, MD, Juan Carlos Hernandez Boluda, Javier F Chaves, PhD, María Isabel Orts, MD, Nuria Yagüe, Paula Amat, MD PhD, Fernando Domingo, Yoana Hernández, Paula Coll, Azahara Fuentes, Enrique Seda, Francisca García, Angeles Muñoz, Carlos Solano, MD PhD, Mar Tormo
Journal: Blood
Blood (2019) 134 (Supplement_1): 5412.
https://doi.org/10.1182/blood-2019-129019
Published: 2019
Journal Articles

Favorable Outcome in Patients with Acute Myeloblastic Leukemia (AML) with NPM1 Mutation Who Present an Inadequate Clearance or Relapse of Minimal/Measurable Residual Disease (MRD): Results of a Preemptive Intervention Policy (CETLAM-2012 Protocol)

Alex Bataller Torralba, MD, Marina Diaz-Beyá, MD, Ana Garrido, MD, Susana Vives, MD, Mar Tormo, MD PhD, Montserrat Arnan Sangerman, MD, Olga Salamero, MD, Antonia Sampol, MD PhD, Rosa Coll, MD, Monica Lopez-Guerra, PhD, Marta Pratcorona, MD PhD, Lurdes Zamora, PhD, Eva Villamón, PhD, Gael Roue, PhD, Adoración Blanco, PhD, Aina Oliver-Caldes, MD, Josep F Nomdedeu, MD, Dolors Colomer, PhD, Salut Brunet, MD PhD, Jorge Sierra, MD, Jordi Esteve, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1385.
https://doi.org/10.1182/blood-2018-99-110895
Published: 2018
Journal Articles

Rapid Screening of Targetable Kinase Gene Fusions in Acute Lymphoblastic Leukemia

Esperanza Such, Gayane Avetisyan, Iván Martín, Inés Gómez-Seguí, PhD, Francisca García, Eva Villamón, PhD, Alessandro Liquori, PhD, Francisco Mares, MD, Marta Llop, Paula Amat, MDPhD, Mariam Ibañez, Eva Barragán, Mar Tormo, MD PhD, Guillermo Sanz, MD, Carlos Solano, MD PhD, José Cervera, MD PhD, Blanca Navarro, Miguel A. Sanz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1436.
https://doi.org/10.1182/blood.V130.Suppl_1.1436.1436
Published: 2017
Journal Articles

Impact of Genemutations and Dynamics Methylation of CDKN2B and DLC-1 Promoters on Treatment Response with Azacitidine

Iván Martín, Alicia Serrano, Blanca Navarro, MDPhD, Eva Villamón, PhD, Pilar Rentero-Garrido, Fernando Domingo, Javier F Chaves, PhD, Victoria Adam, Paula Amat, MDPhD, Marisa Calabuig, MD, Francisca García, Carlos Solano, MD PhD, Mar Tormo, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3932.
https://doi.org/10.1182/blood.V130.Suppl_1.3932.3932
Published: 2017